This segment focuses on developing and commercializing stem cell-based therapies for various diseases. Research and development efforts are directed towards isolating, expanding, and differentiating stem cells for therapeutic applications. Key technologies include bone marrow stem cell derivation and mobilization techniques. The primary therapeutic areas targeted are cardiac repair following myocardial infarction (StromaCel) and liver disease (UMK-121). The goal is to improve patient outcomes by repairing damaged tissues and restoring organ function. Future opportunities include expanding the application of stem cell therapies to other disease areas and developing personalized stem cell treatments. Clinical trials and regulatory approvals are essential for advancing these therapies to market.

This segment focuses on the development and marketing of anti-aging skin care products. The flagship product, Proteoderm, utilizes a proprietary and patented matrix of proteins designed to reduce wrinkles. Research and development activities are centered on identifying and formulating novel protein combinations that enhance skin rejuvenation and reduce the visible signs of aging. The target market includes consumers seeking effective anti-aging solutions. Future opportunities involve expanding the product line with personalized skin care formulations and exploring new delivery methods for active ingredients. Regulatory compliance and safety testing are crucial aspects of this segment.